While Glaxo investigates a compound found in red wine as a potential cancer and diabetes drug, two employees were involved in a nonprofit group selling the substance as a dietary supplement.
By NATASHA SINGER, NY Times: Business
Fri, 08/13/2010 - 8:05am
While Glaxo investigates a compound found in red wine as a potential cancer and diabetes drug, two employees were involved in a nonprofit group selling the substance as a dietary supplement.